NYSE:CLX - The Clorox Stock Price, Price Target & More

$114.96 +1.11 (+0.97 %)
(As of 04/25/2018 01:04 AM ET)
Previous Close$114.96
Today's Range$113.57 - $116.12
52-Week Range$113.57 - $150.40
Volume1.93 million shs
Average Volume1.17 million shs
Market Capitalization$14.87 billion
P/E Ratio21.49
Dividend Yield2.92%
Beta0.35

About The Clorox (NYSE:CLX)

The Clorox logoThe Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighters and color boosters; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning and disinfecting products under the Clorox, Dispatch, Aplicare, HealthLink, and Clorox Healthcare brands. It also provides charcoal products under the Kingsford and Match Light brands; bags, wraps, and containers under the Glad brand; cat litter products under the Fresh Step, Scoop Away, and Ever Clean brands; and digestive health products under the RenewLife brand. In addition, the company offers dressings and sauces primarily under the Hidden Valley, KC Masterpiece, Kingsford, and Soy Vay brands; water-filtration systems and filters under the Brita brand; and natural personal care products under the Burt's Bees brand. Further, it markets its products under the PinoLuz, Ayudin, Limpido, Clorinda, Poett, Mistolin, Lestoil, Bon Bril, Agua Jane, and Chux brands. The company sells its products primarily through mass retail and grocery outlets, warehouse clubs, dollars stores, e-commerce channels, military stores and other retail outlets, and medical supply distributors. The Clorox Company was founded in 1913 and is headquartered in Oakland, California.

Receive CLX News and Ratings via Email

Sign-up to receive the latest news and ratings for CLX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Polishes & sanitation goods
Sub-IndustryHousehold Products
SectorConsumer Staples
SymbolNYSE:CLX
CUSIP18905410
Phone510-271-7000

Debt

Debt-to-Equity Ratio2.35%
Current Ratio1.22%
Quick Ratio0.86%

Price-To-Earnings

Trailing P/E Ratio21.49
Forward P/E Ratio20.38
P/E Growth2.45

Sales & Book Value

Annual Sales$5.97 billion
Price / Sales2.49
Cash Flow$6.7267 per share
Price / Cash17.09
Book Value$4.21 per share
Price / Book27.31

Profitability

EPS (Most Recent Fiscal Year)$5.35
Net Income$701 million
Net Margins13.21%
Return on Equity126.70%
Return on Assets15.69%

Miscellaneous

Employees8,100
Outstanding Shares129,400,000

How to Become a New Pot Stock Millionaire

The Clorox (NYSE:CLX) Frequently Asked Questions

What is The Clorox's stock symbol?

The Clorox trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLX."

How often does The Clorox pay dividends? What is the dividend yield for The Clorox?

The Clorox announced a quarterly dividend on Tuesday, February 13th. Shareholders of record on Wednesday, April 25th will be given a dividend of $0.96 per share on Friday, May 11th. This represents a $3.84 annualized dividend and a yield of 3.34%. The ex-dividend date is Tuesday, April 24th. This is a positive change from The Clorox's previous quarterly dividend of $0.84. View The Clorox's Dividend History.

How were The Clorox's earnings last quarter?

The Clorox Company (NYSE:CLX) posted its quarterly earnings results on Friday, February, 2nd. The company reported $1.23 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.22 by $0.01. The firm had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.43 billion. The Clorox had a return on equity of 126.70% and a net margin of 13.21%. The Clorox's revenue was up .7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.14 EPS. View The Clorox's Earnings History.

When is The Clorox's next earnings date?

The Clorox is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for The Clorox.

What guidance has The Clorox issued on next quarter's earnings?

The Clorox issued an update on its FY18 earnings guidance on Friday, February, 2nd. The company provided earnings per share guidance of $6.17-6.37 for the period, compared to the Thomson Reuters consensus estimate of $5.66. The company issued revenue guidance of +1-3% to ~$6.03-6.15 billion, compared to the consensus revenue estimate of $6.13 billion.

What price target have analysts set for CLX?

12 equities research analysts have issued 12-month price objectives for The Clorox's shares. Their forecasts range from $115.00 to $148.00. On average, they expect The Clorox's share price to reach $132.3464 in the next twelve months. View Analyst Ratings for The Clorox.

What are Wall Street analysts saying about The Clorox stock?

Here are some recent quotes from research analysts about The Clorox stock:
  • 1. According to Zacks Investment Research, "Clorox has underperformed the industry in the last three months. Though it delivered better-than-expected second-quarter fiscal 2018 earnings, which also marked its fifth straight earnings beat, sales lagged the Zacks Consensus Estimate. Further, the company witnessed significant pressure on gross margin in the quarter owing to elevated input costs for commodities and tightening of transportation market, which are likely to continue hurting margins in fiscal 2018. In addition, results were hurt by strategic investments in growth and cost savings initiatives. However, management reiterated sales guidance for fiscal 2018, while it raised the earnings view to include the benefits of the new tax reform. Further, the company’s 2020 Strategy, aimed at bolstering growth for the improvement of categories and overall market share, bodes well. Also, its approach to brand management and Go Lean strategy are noteworthy." (4/9/2018)
  • 2. Wells Fargo analysts commented, "We maintain our Market Perform rating. CLX Is Among The Best Positioned In Our Broader Staples Coverage Universe To Benefit From U.S. Tax Reform – Our detailed analysis of the pot’l reforms across broader Staples indicates that this could generate ~+20% EPS accretion for CLX if lowered from 35% to ~20%. We estimate that up to ~55% of this potential upside from pot’l corporate tax reform is currently priced into shares, implying further upside potential for CLX shares (possibly to ~$155-160/shr) if reforms are implemented. (For details on our quantification, please see p. 4). Continued Confidence in CLX’s FY18 Growth Outlook – Management reiterated its 1-3% FY18 sales growth guidance (we continue to estimate +2.3%). Sales growth is still likely to sequentially moderate in F2Q vs. FQ1 due to: (1) Tougher y/y comparisons; (2) A reversal of hurricane-related sales pull-forward; and (3) A slowdown in the Wipes business as CLX takes pricing." (12/13/2017)
  • 3. Jefferies Group LLC analysts commented, "In what has been a challenging earnings season in HPC/beverages, CLX’s 1Q print was strong w/org sales upside (4% vs. Street ~3%) and better than expected margins driving a 4-cent EPS beat ($1.46 vs. $1.42). CLX trimmed its FY18 EPS guidance by less than 1% to $5.47-$5.67 (vs. Street/JEF $5.64/$5.55), which was likely not as bad as feared (> 2% cut). Valuation still looks full at 22.5x EV/ULFCF, though we’d expect a positive reaction on the print. Solid start to FY18 with high-quality 1Q EPS beat: Reported 1Q revs of $1.50B were 1 pt ahead of consensus as ~4% org sales growth was above Street estimates of +2.9%. Gross margins of 44.9% came in 25 bps above Street est., driving a >1.5% gross profit beat. SG&A was in-line at 24.7% of sales with OI 2.5% ahead of Consensus. Below the line items (lower tax rate and share count partially offset by a modest other income drag) were a $0.02 net benefit vs. our model as EPS of $1.46 beat Street est. by $0.04 on generally good quality." (11/1/2017)

Who are some of The Clorox's key competitors?

Who are The Clorox's key executives?

The Clorox's management team includes the folowing people:
  • Mr. Benno O. Dorer, Chairman & CEO (Age 54)
  • Ms. Dawn C. Willoughby, Exec. VP & COO (Age 49)
  • Ms. Laura Stein, Exec. VP of Corp. Affairs & Gen. Counsel (Age 56)
  • Mr. Stephen M. Robb, Advisor (Age 53)
  • Mr. Kevin B. Jacobsen, Sr. VP & CFO (Age 51)

Has The Clorox been receiving favorable news coverage?

News headlines about CLX stock have trended somewhat positive on Wednesday, Accern reports. Accern ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. The Clorox earned a coverage optimism score of 0.21 on Accern's scale. They also gave news coverage about the company an impact score of 43.94 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of The Clorox?

Shares of CLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is The Clorox's stock price today?

One share of CLX stock can currently be purchased for approximately $114.96.

How big of a company is The Clorox?

The Clorox has a market capitalization of $14.87 billion and generates $5.97 billion in revenue each year. The company earns $701 million in net income (profit) each year or $5.35 on an earnings per share basis. The Clorox employs 8,100 workers across the globe.

How can I contact The Clorox?

The Clorox's mailing address is 1221 BROADWAY, OAKLAND CA, 94612. The company can be reached via phone at 510-271-7000 or via email at [email protected]


MarketBeat Community Rating for The Clorox (CLX)

Community Ranking:  1.3 out of 5 (star)
Outperform Votes:  190 (Vote Outperform)
Underperform Votes:  567 (Vote Underperform)
Total Votes:  757
MarketBeat's community ratings are surveys of what our community members think about The Clorox and other stocks. Vote "Outperform" if you believe CLX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

The Clorox (NYSE:CLX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
12 Wall Street analysts have issued ratings and price targets for The Clorox in the last 12 months. Their average twelve-month price target is $132.3464, suggesting that the stock has a possible upside of 15.12%. The high price target for CLX is $148.00 and the low price target for CLX is $115.00. There are currently 2 sell ratings, 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.082.082.00
Ratings Breakdown: 2 Sell Rating(s)
8 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
10 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
10 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
9 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $132.3464$130.7342$131.50$124.00
Price Target Upside: 15.12% upside1.75% upside8.32% downside3.98% downside

The Clorox (NYSE:CLX) Consensus Price Target History

Price Target History for The Clorox (NYSE:CLX)

The Clorox (NYSE:CLX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/19/2018Wells FargoLower Price TargetMarket Perform$140.00 -> $130.00HighView Rating Details
4/19/2018Morgan StanleyDowngradeEqual Weight -> Underweight$126.72 -> $116.00HighView Rating Details
4/6/2018BarclaysSet Price TargetHold$131.00LowView Rating Details
3/29/2018BMO Capital MarketsSet Price TargetBuy$147.00LowView Rating Details
3/13/2018JPMorgan ChaseReiterated RatingNeutral -> Neutral$139.00 -> $138.00LowView Rating Details
2/8/2018ArgusDowngradeBuy -> Hold$150.40 -> $127.81LowView Rating Details
2/5/2018Bank of AmericaLower Price TargetNeutral -> Neutral$155.00 -> $140.00HighView Rating Details
1/4/2018Jefferies GroupReiterated RatingHold$148.00LowView Rating Details
12/13/2017Deutsche BankInitiated CoverageHold$142.00LowView Rating Details
11/10/2017Consumer EdgeUpgradeNeutral -> OutperformN/AView Rating Details
10/8/2017Royal Bank of CanadaReiterated RatingHold$115.00N/AView Rating Details
5/5/2017UBSReiterated RatingSell$117.00 -> $121.00N/AView Rating Details
4/7/2017CitigroupBoost Price TargetNeutral$75.00 -> $76.00LowView Rating Details
2/11/2017B. RileyReiterated RatingNeutral$125.00N/AView Rating Details
9/16/2016Atlantic SecuritiesUpgradeHold -> Buy$144.00N/AView Rating Details
8/4/2016Goldman SachsReiterated RatingNeutral$130.00N/AView Rating Details
(Data available from 4/25/2016 forward)

Earnings

The Clorox (NYSE:CLX) Earnings History and Estimates Chart

Earnings by Quarter for The Clorox (NYSE:CLX)

The Clorox (NYSE:CLX) Earnings Estimates

2018 EPS Consensus Estimate: $5.62
2019 EPS Consensus Estimate: $6.50
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$1.39$1.42$1.41
Q2 20183$1.19$1.38$1.27
Q3 20183$1.29$1.37$1.32
Q4 20183$1.58$1.66$1.63
Q1 20191$1.71$1.71$1.71
Q2 20191$1.44$1.44$1.44
Q3 20191$1.46$1.46$1.46
Q4 20191$1.89$1.89$1.89

The Clorox (NYSE CLX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018$1.31N/AView Earnings Details
2/2/2018Q2 2018$1.22$1.23$1.4287 billion$1.4160 billionViewListenView Earnings Details
11/1/2017Q1 2018$1.41$1.46$1.4833 billion$1.50 billionViewN/AView Earnings Details
8/3/2017Q4 2017$1.49$1.53$1.6455 billion$1.6470 billionViewListenView Earnings Details
5/3/2017Q3 2017$1.2970$1.3090$1.4819 billion$1.4770 billionViewListenView Earnings Details
2/3/2017Q217$1.22$1.25$1.41 billion$1.41 billionViewN/AView Earnings Details
11/2/2016Q117$1.42$1.36$1.24 billion$1.44 billionViewN/AView Earnings Details
8/3/2016Q416$1.28$1.26$1.58 billion$1.60 billionViewListenView Earnings Details
5/3/2016Q316$1.11$1.21$1.41 billion$1.43 billionViewN/AView Earnings Details
2/4/2016Q216$1.05$1.14$1.35 billion$1.35 billionViewListenView Earnings Details
11/2/2015Q116$1.18$1.32$1.37 billion$1.39 billionViewListenView Earnings Details
8/3/2015Q415$1.37$1.44$1.52 billion$1.5570 billionViewN/AView Earnings Details
5/1/2015Q315$1.10$1.08$1.38 billion$1.4010 billionViewListenView Earnings Details
2/4/2015Q215$0.90$0.97$1.30 billion$1.35 billionViewListenView Earnings Details
10/31/2014Q115$1.03$1.10$1.33 billion$1.35 billionViewListenView Earnings Details
8/1/2014Q4$1.34$1.40$1.5245 billion$1.5110 billionViewListenView Earnings Details
5/1/2014Q314$1.08$1.18$1.43 billion$1.3860 billionViewN/AView Earnings Details
2/4/2014Q214$0.91$0.88$1.31 billion$1.33 billionViewN/AView Earnings Details
10/31/2013Q114$1.01$1.04$1.35 billion$1.3640 billionViewN/AView Earnings Details
8/1/2013Q4 2013$1.34$1.38$1.57 billion$1.55 billionViewN/AView Earnings Details
5/1/2013Q3 2013$1.06$1.00$1.44 billion$1.41 billionViewN/AView Earnings Details
2/4/2013Q2 2013$0.80$0.90$1.27 billion$1.3250 billionViewN/AView Earnings Details
10/31/2012Q113$0.95$1.01$1.35 billion$1.34 billionViewN/AView Earnings Details
8/2/2012$1.27$1.32ViewN/AView Earnings Details
5/2/2012$1.04$1.02ViewN/AView Earnings Details
2/3/2012$0.69$0.79ViewN/AView Earnings Details
11/2/2011$0.93$1.04ViewN/AView Earnings Details
8/3/2011$1.20$1.26ViewN/AView Earnings Details
5/3/2011$1.04$1.02ViewN/AView Earnings Details
2/4/2011$0.61$0.68ViewN/AView Earnings Details
11/2/2010Q1 2011$1.13$1.08ViewN/AView Earnings Details
8/3/2010Q4 2010$1.20$1.22ViewN/AView Earnings Details
5/3/2010Q3 2010$1.09$1.16ViewN/AView Earnings Details
2/4/2010Q2 2010$0.75$0.77ViewN/AView Earnings Details
11/2/2009Q1 2010$0.95$1.14ViewN/AView Earnings Details
8/3/2009Q4 2009$1.20$1.25ViewN/AView Earnings Details
5/1/2009Q3 2009$0.90$1.08ViewN/AView Earnings Details
2/4/2009Q2 2009$0.58$0.62ViewN/AView Earnings Details
10/31/2008Q1 2009$0.84$0.95ViewN/AView Earnings Details
8/1/2008Q4 2008$1.11$1.18ViewN/AView Earnings Details
5/1/2008Q3 2008$0.77$0.84ViewN/AView Earnings Details
2/4/2008Q2 2008$0.56$0.69ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

The Clorox (NYSE:CLX) Dividend Information

The Clorox pays an annual dividend of $3.36 per share, with a dividend yield of 2.92%. CLX's next quarterly dividend payment will be made on Friday, May 11. The company has grown its dividend for the last 40 consecutive years and is increasing its dividend by an average of 4.20% each year. The Clorox pays out 62.80% of its earnings out as a dividend.
Next Dividend:5/11/2018
Annual Dividend:$3.36
Dividend Yield:2.92%
Dividend Growth:4.20% (3 Year Average)
Payout Ratio:62.80% (Trailing 12 Months of Earnings)
59.57% (Based on This Year's Estimates)
52.26% (Based on Next Year's Estimates)
Track Record:40 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for The Clorox (NYSE:CLX)

The Clorox (NYSE:CLX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/13/2018Quarterly$0.964/24/20184/25/20185/11/2018
11/14/2017quarterly$0.842.53%1/23/20181/24/20182/9/2018
9/13/2017Quarterly$0.842.49%10/24/201710/25/201711/13/2017
5/8/2017quarterly$0.847/17/20177/19/20178/4/2017
2/7/2017quarterly$0.802.52%4/17/20174/19/20175/5/2017
11/15/2016quarterly$0.802.81%1/23/20171/25/20172/10/2017
9/13/2016quarterly$0.802.61%10/24/201610/26/201611/14/2016
5/16/2016quarterly$0.802.5%7/25/20167/27/20168/12/2016
2/9/2016quarterly$0.772.43%4/18/20164/20/20165/6/2016
11/17/2015quarterly$0.772.49%1/25/20161/27/20162/12/2016
9/16/2015quarterly$0.772.71%10/26/201510/28/201511/13/2015
5/11/2015quarterly$0.772.87%7/20/20157/22/20158/7/2015
2/10/2015quarterly$0.742.73%4/20/20154/22/20155/8/2015
11/18/2014quarterly$0.742.94%1/26/20151/28/20152/13/2015
9/16/2014quarterly$0.743.3%10/27/201410/29/201411/14/2014
5/12/2014quarterly$0.743.33%7/21/20147/23/20148/8/2014
2/11/2014quarterly$0.713.28%4/21/20144/23/20145/9/2014
11/19/2013quarterly$0.713.07%1/27/20141/29/20142/14/2014
9/17/2013quarterly$0.713.38%10/28/201310/30/201311/15/2013
5/13/2013quarterly$0.713.22%7/22/20137/24/20138/9/2013
2/13/2013quarterly$0.643.15%4/22/20134/24/20135/10/2013
(Data available from 1/1/2013 forward)

Insider Trades

The Clorox (NYSE CLX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.00%
Institutional Ownership Percentage: 75.64%
Insider Trading History for The Clorox (NYSE:CLX)
Institutional Ownership by Quarter for The Clorox (NYSE:CLX)

The Clorox (NYSE CLX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/28/2017Michael R CostelloSVPSell10,574$136.01$1,438,169.7434,867View SEC Filing  
11/8/2017Matthew T LaszloSVPSell20,051$130.46$2,615,853.4610,896View SEC Filing  
8/29/2017Dawn C. WilloughbyCOOSell2,158$138.00$297,804.00View SEC Filing  
8/23/2017James E FosterEVPSell9,861$138.51$1,365,847.1122,069View SEC Filing  
8/23/2017Jon M BalousekSVPSell9,223$138.87$1,280,798.0120,614View SEC Filing  
12/1/2016A D David MackayDirectorBuy5,000$114.90$574,500.00View SEC Filing  
9/2/2016Laura SteinEVPSell38,882$131.69$5,120,370.5848,501View SEC Filing  
8/29/2016Jon M BalousekSVPSell5,136$131.14$673,535.0415,384View SEC Filing  
8/17/2016Dawn C WilloughbyCOOSell10,617$131.01$1,390,933.1720,353View SEC Filing  
8/10/2016Nikolaos A. VlahosCOOSell925$133.07$123,089.75View SEC Filing  
5/10/2016Nikolaos A VlahosCOOSell2,151$132.25$284,469.7513,883View SEC Filing  
2/24/2016Dawn C WilloughbyCOOSell1,550$129.00$199,950.0010,749View SEC Filing  
2/8/2016Nikolaos A. VlahosCOOSell8,589$126.60$1,087,367.4012,448View SEC Filing  
12/7/2015Jon M BalousekSVPSell1,488$128.69$191,490.7210,186View SEC Filing  
12/4/2015Jacqueline P KaneEVPSell852$127.55$108,672.6022,411View SEC Filing  
12/3/2015Thomas D JohnsonVPSell908$126.09$114,489.7213,458View SEC Filing  
11/27/2015Jacqueline P KaneEVPSell2,160$125.45$270,972.0023,263View SEC Filing  
11/25/2015Thomas D. JohnsonVPSell12,679$125.04$1,585,382.1614,366View SEC Filing  
11/19/2015Laura SteinEVPSell12,700$124.42$1,580,134.0048,629View SEC Filing  
11/17/2015Stephen RobbCFOSell30,496$122.02$3,721,121.9224,006View SEC Filing  
11/12/2015James E. FosterEVPSell5,684$122.24$694,812.1612,787View SEC Filing  
11/11/2015Laura SteinEVPSell17,577$124.21$2,183,239.1746,582View SEC Filing  
11/4/2015Dawn C. WilloughbyCOOSell29,349$124.06$3,641,036.9410,749View SEC Filing  
11/4/2015Laura SteinEVPSell8,716$124.50$1,085,142.0046,582View SEC Filing  
10/6/2015Stephen RobbCFOSell19,125$119.00$2,275,875.0022,035View SEC Filing  
9/25/2015Jacqueline P KaneEVPSell2,340$115.00$269,100.0025,423View SEC Filing  
9/25/2015Stephen RobbCFOSell21,020$115.00$2,417,300.0020,910View SEC Filing  
9/18/2015Stephen RobbCFOSell8,500$113.85$967,725.0019,500View SEC Filing  
9/17/2015Jacqueline P KaneEVPSell5,027$115.00$578,105.0027,573View SEC Filing  
9/14/2015James E. FosterEVPSell11,999$109.34$1,311,970.6613,287View SEC Filing  
9/8/2015Jon M BalousekSVPSell1,294$111.38$144,125.7210,733View SEC Filing  
9/2/2015Frank A TataseoEVPSell3,673$110.25$404,948.2524,054View SEC Filing  
8/28/2015Thomas D JohnsonVPSell1,051$111.34$117,018.3413,812View SEC Filing  
8/27/2015James E FosterEVPSell3,000$111.39$334,170.0012,495View SEC Filing  
8/20/2015Nikolaos A VlahosCOOSell4,800$116.12$557,376.0011,644View SEC Filing  
6/16/2015Jeffrey T KlendaDirectorBuy394,257$0.20$78,851.40
3/25/2015Jeffrey T KlendaDirectorBuy25,000$0.1550$3,875.00
3/23/2015Dawn C WilloughbyCOOSell5,440$112.00$609,280.00View SEC Filing  
3/16/2015Stephen RobbCFOSell25,279$109.49$2,767,797.71View SEC Filing  
2/12/2015Nikolaos A VlahosCOOSell16,018$108.01$1,730,104.18View SEC Filing  
2/10/2015Frank A TataseoEVPSell86,087$107.01$9,212,169.87View SEC Filing  
2/6/2015Donald R KnaussChairmanSell272,780$106.83$29,141,087.40View SEC Filing  
1/9/2015James E FosterEVPSell19,048$106.68$2,032,040.64View SEC Filing  
1/5/2015Jacqueline P KaneSVPSell23,534$103.76$2,441,887.84View SEC Filing  
12/22/2014Donald R KnaussChairmanSell270,853$104.06$28,184,963.18View SEC Filing  
12/8/2014Nikolaos A VlahosCOOSell7,394$99.60$736,442.40View SEC Filing  
11/26/2014James E FosterEVPSell15,315$99.74$1,527,518.10View SEC Filing  
11/26/2014Thomas D JohnsonVPSell25,006$99.52$2,488,597.12View SEC Filing  
11/25/2014Jacqueline P KaneSVPSell43,430$99.50$4,321,285.00View SEC Filing  
11/13/2014Dawn C WilloughbyCOOSell4,034$102.02$411,548.68View SEC Filing  
11/13/2014Michael R CostelloSVPSell16,348$102.00$1,667,496.00View SEC Filing  
11/3/2014George C RoethCOOSell198,159$99.46$19,708,894.14View SEC Filing  
9/22/2014Jacqueline P KaneSVPSell43,960$97.00$4,264,120.00View SEC Filing  
8/25/2014Benno O DorerCOOSell2,505$89.12$223,245.60View SEC Filing  
6/9/2014Thomas D JohnsonVPSell23,737$89.44$2,123,037.28View SEC Filing  
5/20/2014Thomas BritanikCMOSell1,779$88.48$157,405.9211,808View SEC Filing  
5/8/2014Thomas BritanikCMOSell21,320$88.00$1,876,160.0013,587View SEC Filing  
4/29/2014Wayne DelkerSVPSell14,819$92.00$1,363,348.0013,640View SEC Filing  
3/27/2014Dawn WilloughbySVPSell2,595$90.00$233,550.001,864View SEC Filing  
12/3/2013Grant LamontagneSVPSell71,860$93.01$6,683,698.6019,736View SEC Filing  
11/22/2013Jon BalousekSVPSell3,125$93.72$292,875.006,396View SEC Filing  
11/7/2013Thomas P BritanikCMOSell5,834$92.03$536,903.02View SEC Filing  
11/5/2013Carolyn M TicknorDirectorSell8,000$90.01$720,080.00View SEC Filing  
10/29/2013Benno O DorerCOOSell15,577$90.25$1,405,824.25View SEC Filing  
10/29/2013Frank A TataseoEVPSell25,200$90.27$2,274,804.00View SEC Filing  
7/9/2013Benno O DorerCOOSell25,714$85.14$2,189,289.96View SEC Filing  
6/14/2013Frank A TataseoEVPSell1,197$85.17$101,948.49View SEC Filing  
6/3/2013Thomas P BritanikCMOSell2,278$83.59$190,418.02View SEC Filing  
5/29/2013Tully M FriedmanDirectorSell3,000$84.79$254,370.00View SEC Filing  
5/24/2013Michael R CostelloVPSell1,217$85.98$104,637.66View SEC Filing  
5/16/2013Thomas P BritanikCMOSell34,258$87.81$3,008,194.98View SEC Filing  
5/15/2013George J HaradDirectorSell5,497$87.19$479,283.43View SEC Filing  
5/15/2013Grant J LamontagneSVPSell19,350$87.62$1,695,447.00View SEC Filing  
5/7/2013Nikolaos A VlahosSVPSell3,769$86.15$324,699.35View SEC Filing  
2/22/2013Larry PeirosCOOSell77,200$83.00$6,407,600.00View SEC Filing  
2/1/2013Larry PeirosCOOSell10,678$79.24$846,124.72View SEC Filing  
2/1/2013Stephen RobbCFOSell8,781$79.29$696,245.49View SEC Filing  
12/10/2012George J HaradDirectorBuy3,000$75.95$227,850.00View SEC Filing  
12/4/2012Laura SteinSVPSell26,780$76.34$2,044,385.20View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

The Clorox (NYSE CLX) News Headlines

Source:
DateHeadline
Clorox And The Relative Safety Of DividendsClorox And The Relative Safety Of Dividends
seekingalpha.com - April 24 at 5:29 PM
EX-Dividend Schedule: Clorox Raised its Dividend By 14%; Will Trade Ex-Dividend on April 24, 2018EX-Dividend Schedule: Clorox Raised its Dividend By 14%; Will Trade Ex-Dividend on April 24, 2018
finance.yahoo.com - April 23 at 8:54 AM
The Clorox (CLX) Downgraded to "Sell" at ValuEngineThe Clorox (CLX) Downgraded to "Sell" at ValuEngine
www.americanbankingnews.com - April 21 at 8:42 AM
Today’s Research Reports on Stocks to Watch: The Clorox Company and Procter & GambleToday’s Research Reports on Stocks to Watch: The Clorox Company and Procter & Gamble
finance.yahoo.com - April 20 at 5:37 PM
The Clorox (CLX) Rating Increased to Buy at Zacks Investment ResearchThe Clorox (CLX) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - April 20 at 12:58 AM
Oversold Conditions For Clorox (CLX)Oversold Conditions For Clorox (CLX)
www.nasdaq.com - April 19 at 5:49 PM
Gillette and Tide maker struggles in tough environmentGillette and Tide maker struggles in 'tough environment'
www.msn.com - April 19 at 5:49 PM
Notable Thursday Option Activity: MO, CLX, GWWNotable Thursday Option Activity: MO, CLX, GWW
www.nasdaq.com - April 19 at 5:49 PM
Why Align Technology, Taiwan Semiconductor Manufacturing, and Clorox Slumped TodayWhy Align Technology, Taiwan Semiconductor Manufacturing, and Clorox Slumped Today
finance.yahoo.com - April 19 at 5:49 PM
Will Colgate-Palmolive Sustain Sales Momentum in 1Q18?Will Colgate-Palmolive Sustain Sales Momentum in 1Q18?
finance.yahoo.com - April 19 at 5:49 PM
The Clorox Company (CLX) Given Average Recommendation of "Hold" by BrokeragesThe Clorox Company (CLX) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 19 at 1:35 PM
The Clorox (CLX) Cut to Underweight at Morgan StanleyThe Clorox (CLX) Cut to Underweight at Morgan Stanley
www.americanbankingnews.com - April 19 at 10:01 AM
Wells Fargo Lowers The Clorox (CLX) Price Target to $130.00Wells Fargo Lowers The Clorox (CLX) Price Target to $130.00
www.americanbankingnews.com - April 19 at 9:28 AM
Clorox Announces May 8 Webcast of Company Presentation at Goldman Sachs Global Staples ForumClorox Announces May 8 Webcast of Company Presentation at Goldman Sachs Global Staples Forum
finance.yahoo.com - April 19 at 8:37 AM
The Clorox Company (CLX) Declares Dividend Increase - $0.96 Per ShareThe Clorox Company (CLX) Declares Dividend Increase - $0.96 Per Share
www.americanbankingnews.com - April 19 at 8:18 AM
The Clorox (CLX) Downgraded to Strong Sell at BidaskClubThe Clorox (CLX) Downgraded to Strong Sell at BidaskClub
www.americanbankingnews.com - April 16 at 8:40 PM
Zacks Investment Research Downgrades The Clorox (CLX) to HoldZacks Investment Research Downgrades The Clorox (CLX) to Hold
www.americanbankingnews.com - April 15 at 8:37 AM
The Clorox (CLX) Rating Increased to Sell at BidaskClubThe Clorox (CLX) Rating Increased to Sell at BidaskClub
www.americanbankingnews.com - April 15 at 12:04 AM
Royal Bank of Canada Reiterates "Hold" Rating for The Clorox (CLX)Royal Bank of Canada Reiterates "Hold" Rating for The Clorox (CLX)
www.americanbankingnews.com - April 14 at 11:49 AM
 Brokerages Anticipate The Clorox Company (CLX) Will Announce Quarterly Sales of $1.51 Billion Brokerages Anticipate The Clorox Company (CLX) Will Announce Quarterly Sales of $1.51 Billion
www.americanbankingnews.com - April 14 at 3:53 AM
Will Cost Savings Drive Kimberly-Clark’s Q1 Earnings Higher?Will Cost Savings Drive Kimberly-Clark’s Q1 Earnings Higher?
finance.yahoo.com - April 13 at 5:33 PM
The Clorox (CLX) Given a $150.00 Price Target at BMO Capital MarketsThe Clorox (CLX) Given a $150.00 Price Target at BMO Capital Markets
www.americanbankingnews.com - April 13 at 10:53 AM
Zacks: Brokerages Anticipate The Clorox Company (CLX) Will Post Earnings of $1.31 Per ShareZacks: Brokerages Anticipate The Clorox Company (CLX) Will Post Earnings of $1.31 Per Share
www.americanbankingnews.com - April 12 at 9:19 AM
Jefferies Group Reaffirms "Hold" Rating for The Clorox (CLX)Jefferies Group Reaffirms "Hold" Rating for The Clorox (CLX)
www.americanbankingnews.com - April 11 at 7:53 PM
What’s behind Procter & Gamble’s Improving Dividend Trend?What’s behind Procter & Gamble’s Improving Dividend Trend?
finance.yahoo.com - April 11 at 8:29 AM
Zacks Investment Research Lowers The Clorox (CLX) to SellZacks Investment Research Lowers The Clorox (CLX) to Sell
www.americanbankingnews.com - April 9 at 1:55 PM
The Clorox (CLX) Stock Rating Reaffirmed by BMO Capital MarketsThe Clorox (CLX) Stock Rating Reaffirmed by BMO Capital Markets
www.americanbankingnews.com - April 8 at 11:55 PM
The Clorox (CLX) PT Set at $131.00 by BarclaysThe Clorox (CLX) PT Set at $131.00 by Barclays
www.americanbankingnews.com - April 7 at 11:26 AM
The Clorox (CLX) PT Lowered to $128.00The Clorox (CLX) PT Lowered to $128.00
www.americanbankingnews.com - April 5 at 12:57 PM
Brokers Set Expectations for The Clorox Companys Q1 2019 Earnings (CLX)Brokers Set Expectations for The Clorox Company's Q1 2019 Earnings (CLX)
www.americanbankingnews.com - April 4 at 7:58 AM
Q4 2018 EPS Estimates for The Clorox Company Reduced by KeyCorp (CLX)Q4 2018 EPS Estimates for The Clorox Company Reduced by KeyCorp (CLX)
www.americanbankingnews.com - April 3 at 7:44 AM
The Clorox (CLX) Receives Hold Rating from Jefferies GroupThe Clorox (CLX) Receives Hold Rating from Jefferies Group
www.americanbankingnews.com - April 2 at 1:30 PM
Clorox: Buy Or Hold?Clorox: Buy Or Hold?
seekingalpha.com - April 2 at 9:07 AM
The Clorox (CLX) PT Lowered to $128.00 at Morgan StanleyThe Clorox (CLX) PT Lowered to $128.00 at Morgan Stanley
www.americanbankingnews.com - April 1 at 10:20 PM
Screening The Canadian Market For Dividend Growth Consumer StaplesScreening The Canadian Market For Dividend Growth Consumer Staples
seekingalpha.com - April 1 at 8:20 AM
Brita® And Stephen Curry Seek To Make A Long-Lasting Impact In Schools NationwideBrita® And Stephen Curry Seek To Make A Long-Lasting Impact In Schools Nationwide
finance.yahoo.com - March 30 at 5:36 PM
Can The Clorox Company’s (NYSE:CLX) ROE Continue To Surpass The Industry Average?Can The Clorox Company’s (NYSE:CLX) ROE Continue To Surpass The Industry Average?
finance.yahoo.com - March 30 at 5:36 PM
The Clorox (CLX) Raised to "Neutral" at Bank of AmericaThe Clorox (CLX) Raised to "Neutral" at Bank of America
www.americanbankingnews.com - March 30 at 4:32 PM
The Clorox (CLX) Stock Rating Upgraded by Zacks Investment ResearchThe Clorox (CLX) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - March 30 at 12:04 PM
The Clorox (CLX) vs. Coty (COTY) Head to Head SurveyThe Clorox (CLX) vs. Coty (COTY) Head to Head Survey
www.americanbankingnews.com - March 29 at 9:19 PM
After the Bell: Dows 250-Point Gain Cant Undo All Marchs DamageAfter the Bell: Dow's 250-Point Gain Can't Undo All March's Damage
finance.yahoo.com - March 29 at 5:27 PM
The Clorox (CLX) Given a $147.00 Price Target by BMO Capital Markets AnalystsThe Clorox (CLX) Given a $147.00 Price Target by BMO Capital Markets Analysts
www.americanbankingnews.com - March 29 at 11:16 AM
Cramer Remix: The stock to get into if you can’t take the pain in techCramer Remix: The stock to get into if you can’t take the pain in tech
www.cnbc.com - March 28 at 7:17 PM
The Clorox (CLX) vs. Its Competitors Financial ComparisonThe Clorox (CLX) vs. Its Competitors Financial Comparison
www.americanbankingnews.com - March 28 at 9:59 AM
$1.51 Billion in Sales Expected for The Clorox Company (CLX) This Quarter$1.51 Billion in Sales Expected for The Clorox Company (CLX) This Quarter
www.americanbankingnews.com - March 28 at 9:24 AM
105-Year-Old Company Beats Market Sell-offs105-Year-Old Company Beats Market Sell-offs
finance.yahoo.com - March 28 at 8:00 AM
Clorox Announces May 2 Webcast of Third-Quarter Fiscal Year 2018 ResultsClorox Announces May 2 Webcast of Third-Quarter Fiscal Year 2018 Results
finance.yahoo.com - March 28 at 8:00 AM
Dividend Stock Analysis: The Clorox CompanyDividend Stock Analysis: The Clorox Company
seekingalpha.com - March 27 at 5:32 PM
Green Biologics Partners With Kingsford® Charcoal to Launch New EcoLight™ Natural Charcoal Lighter FluidGreen Biologics Partners With Kingsford® Charcoal to Launch New EcoLight™ Natural Charcoal Lighter Fluid
finance.yahoo.com - March 27 at 5:32 PM
$1.31 Earnings Per Share Expected for The Clorox Company (CLX) This Quarter$1.31 Earnings Per Share Expected for The Clorox Company (CLX) This Quarter
www.americanbankingnews.com - March 26 at 11:14 AM

SEC Filings

The Clorox (NYSE:CLX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

The Clorox (NYSE:CLX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

The Clorox (NYSE CLX) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.